Observational Study of Perioperative Chemotherapy in Gastric Cancer
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and toxicity of perioperative chemotherapy with
Epirubicin + Cisplatin + Capecitabine (ECX) in routine clinical practice in a network of
public hospitals in Santiago, Chile.
Details
Lead Sponsor:
Grupo Oncologico Cooperativo Chileno de Investigation